Anika Therapeutics, Inc.
SEC Filing List
ANIK CIK: 0000898437
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Henneman John B Iii | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| 4 | Statement of changes in beneficial owner... | Griffin Stephen D. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Anika Therapeutics, Inc. | GLOBENEWSWIRE INC. /fa | 04/30/2026 | |
| 8-K | Current report filing | Anika Therapeutics, Inc. | GLOBENEWSWIRE INC. /fa | 04/29/2026 | |
| SCHEDULE 13G | 04/29/2026 | ||||
| DEFA14A | Definitive additional proxy soliciting m... | Anika Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/28/2026 | |
| DEF 14A | Definitive proxy statements | Anika Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/28/2026 | |
| ARS | Annual report to security holders | Anika Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/28/2026 | |
| SCHEDULE 13G/A | 03/26/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Mcleod Ian | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/23/2026 | |
| No record found. | |||||
| Load More | |||||
